Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Hahn: FDA May Keep Some COVID-19 Reforms Post-Pandemic

Jun 19 2020

• By Elizabeth Orr

Stephen Hahn in his 1st address to the FDA January 30, 2020 — Stephen Hahn

Additional Topics

United States Coronavirus COVID-19 Policy FDA Post Market Regulation & Studies Respiratory Diagnostics In Vitro Diagnostics Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window